CALGARY, AB and SAN FRANCISCO, March 16, 2022 /PRNewswire/ -- Circle Cardiovascular Imaging Inc. ("Circle CVI"), the global leader in cardiovascular imaging solutions, today announced a strategic growth investment from Thoma Bravo, a leading software investment firm. Thoma Bravo's partnership is expected to drive future investment in product innovation, extend Circle CVI's market leadership position and fuel future growth. Financial terms of the transaction were not disclosed.
Circle CVI is the leading provider of AI-based cardiac imaging and reporting solutions, including cardiac MRI ("CMR") and cardiac computerized tomography ("CT") imaging post-processing software. The company has developed a deep portfolio of specialized, accurate and intuitive solutions that enable physicians to deliver the highest quality care to their patients. Circle CVI's solutions are an integral part of precision medicine and are now used by thousands of clinical users, at both hospitals and academic institutions, in more than 50 countries. Thoma Bravo's investment will bring significant operational and financial resources to accelerate the company's leadership and growth in the global cardiac imaging industry.
"We're excited to partner with Thoma Bravo, one of the world's largest and most experienced software investors, as we embark on the next phase of our growth journey and expand our market-leading position," said Greg Ogrodnick, CEO and Co-Founder of Circle CVI. "Thoma Bravo's operational expertise and partnership-oriented approach will help us drive innovation and bring even more best-in-class solutions to physicians, patients and hospitals all over the world."
"This partnership positions Circle CVI to help even more patients around the world by supporting the continued development of our diverse suite of products," said Matthias Friedrich, Chief Design Officer and Co-Founder of Circle CVI. "Thoma Bravo's investment reflects their strong appreciation for our commitment to excellence in imaging, and their team's significant experience in backing software market leaders makes them an ideal partner."
"Circle CVI has long been at the leading edge of cardiac image post-processing solutions, and that commitment to innovation has led the company to become one of the world's most trusted partners in cardiovascular health," said Carl Press, a Partner at Thoma Bravo. "We're thrilled to partner with Greg and the Circle CVI team to build on their impressive momentum."
